199 related articles for article (PubMed ID: 11531923)
1. Bone metabolism and body composition in Japanese patients with active acromegaly.
Kaji H; Sugimoto T; Nakaoka D; Okimura Y; Kaji H; Abe H; Chihara K
Clin Endocrinol (Oxf); 2001 Aug; 55(2):175-81. PubMed ID: 11531923
[TBL] [Abstract][Full Text] [Related]
2. Determinants of bone mineral density and spinal fracture risk in postmenopausal Japanese women.
Nakaoka D; Sugimoto T; Kaji H; Kanzawa M; Yano S; Yamauchi M; Sugishita T; Chihara K
Osteoporos Int; 2001; 12(7):548-54. PubMed ID: 11527051
[TBL] [Abstract][Full Text] [Related]
3. Skeletal involvement in female acromegalic subjects: the effects of growth hormone excess in amenorrheal and menstruating patients.
Scillitani A; Chiodini I; Carnevale V; Giannatempo GM; Frusciante V; Villella M; Pileri M; Guglielmi G; Di Giorgio A; Modoni S; Fusilli S; Di Cerbo A; Liuzzi A
J Bone Miner Res; 1997 Oct; 12(10):1729-36. PubMed ID: 9333135
[TBL] [Abstract][Full Text] [Related]
4. Bone mineral, histomorphometry, and body composition in adults with growth hormone receptor deficiency.
Bachrach LK; Marcus R; Ott SM; Rosenbloom AL; Vasconez O; Martinez V; Martinez AL; Rosenfeld RG; Guevara-Aguirre J
J Bone Miner Res; 1998 Mar; 13(3):415-21. PubMed ID: 9525342
[TBL] [Abstract][Full Text] [Related]
5. Gonadal status is an important determinant of bone density in acromegaly.
Lesse GP; Fraser WD; Farquharson R; Hipkin L; Vora JP
Clin Endocrinol (Oxf); 1998 Jan; 48(1):59-65. PubMed ID: 9509069
[TBL] [Abstract][Full Text] [Related]
6. Long-term maintenance of the anabolic effects of GH on the skeleton in successfully treated patients with acromegaly.
Biermasz NR; Hamdy NA; Pereira AM; Romijn JA; Roelfsema F
Eur J Endocrinol; 2005 Jan; 152(1):53-60. PubMed ID: 15762187
[TBL] [Abstract][Full Text] [Related]
7. A link between bone mineral density and serum adiponectin and visfatin levels in acromegaly.
Sucunza N; Barahona MJ; Resmini E; Fernández-Real JM; Ricart W; Farrerons J; Rodríguez Espinosa J; Marin AM; Puig T; Webb SM
J Clin Endocrinol Metab; 2009 Oct; 94(10):3889-96. PubMed ID: 19723758
[TBL] [Abstract][Full Text] [Related]
8. Bone mineral density and parameters of bone metabolism in patients with acromegaly.
Kotzmann H; Bernecker P; Hübsch P; Pietschmann P; Woloszczuk W; Svoboda T; Geyer G; Luger A
J Bone Miner Res; 1993 Apr; 8(4):459-65. PubMed ID: 8475795
[TBL] [Abstract][Full Text] [Related]
9. Bone mineral content and bone metabolism during physiological GH treatment in GH-deficient adults--an 18-month randomised, placebo-controlled, double blinded trial.
Sneppen SB; Hoeck HC; Kollerup G; Sørensen OH; Laurberg P; Feldt-Rasmussen U
Eur J Endocrinol; 2002 Feb; 146(2):187-95. PubMed ID: 11834427
[TBL] [Abstract][Full Text] [Related]
10. Serum levels of insulin-like growth factor system components and relationship to bone metabolism in Type 1 and Type 2 diabetes mellitus patients.
Jehle PM; Jehle DR; Mohan S; Böhm BO
J Endocrinol; 1998 Nov; 159(2):297-306. PubMed ID: 9795371
[TBL] [Abstract][Full Text] [Related]
11. Effects of GH-IGF-I excess and gonadal status on bone mineral density and body composition in patients with acromegaly.
Madeira M; Neto LV; de Lima GA; Moreira RO; de Mendonça LM; Gadelha MR; Farias ML
Osteoporos Int; 2010 Dec; 21(12):2019-25. PubMed ID: 20306022
[TBL] [Abstract][Full Text] [Related]
12. Serum levels of insulin-like growth factor (IGF); IGF-binding proteins-3, -4, and -5; and their relationships to bone mineral density and the risk of vertebral fractures in postmenopausal women.
Yamaguchi T; Kanatani M; Yamauchi M; Kaji H; Sugishita T; Baylink DJ; Mohan S; Chihara K; Sugimoto T
Calcif Tissue Int; 2006 Jan; 78(1):18-24. PubMed ID: 16397738
[TBL] [Abstract][Full Text] [Related]
13. In acromegaly, increased bone mineral density (BMD) is determined by GH-excess, gonadal function and gender.
Zgliczynski W; Kochman M; Misiorowski W; Zdunowski P
Neuro Endocrinol Lett; 2007 Oct; 28(5):621-8. PubMed ID: 17984937
[TBL] [Abstract][Full Text] [Related]
14. Bone mineral density in acromegaly: the effect of gender, disease activity and gonadal status.
Scillitani A; Battista C; Chiodini I; Carnevale V; Fusilli S; Ciccarelli E; Terzolo M; Oppizzi G; Arosio M; Gasperi M; Arnaldi G; Colao A; Baldelli R; Ghiggi MR; Gaia D; Di Somma C; Trischitta V; Liuzzi A
Clin Endocrinol (Oxf); 2003 Jun; 58(6):725-31. PubMed ID: 12780749
[TBL] [Abstract][Full Text] [Related]
15. Effect of low-dose of recombinant human growth hormone on bone metabolism in elderly women with osteoporosis.
Sugimoto T; Kaji H; Nakaoka D; Yamauchi M; Yano S; Sugishita T; Baylink DJ; Mohan S; Chihara K
Eur J Endocrinol; 2002 Sep; 147(3):339-48. PubMed ID: 12213671
[TBL] [Abstract][Full Text] [Related]
16. Osteopenia occurs in a minority of patients with acromegaly and is predominant in the spine.
Kayath MJ; Vieira JG
Osteoporos Int; 1997; 7(3):226-30. PubMed ID: 9205635
[TBL] [Abstract][Full Text] [Related]
17. Bone mineral density of the axial skeleton in acromegaly.
Ho PJ; Fig LM; Barkan AL; Shapiro B
J Nucl Med; 1992 Sep; 33(9):1608-12. PubMed ID: 1517833
[TBL] [Abstract][Full Text] [Related]
18. Serum levels of insulin-like growth factor (IGF) I, IGF-binding protein (IGFBP)-2, and IGFBP-3 in osteoporotic patients with and without spinal fractures.
Sugimoto T; Nishiyama K; Kuribayashi F; Chihara K
J Bone Miner Res; 1997 Aug; 12(8):1272-9. PubMed ID: 9258758
[TBL] [Abstract][Full Text] [Related]
19. Quantitative ultrasound of the heel and some parameters of bone turnover in patients with acromegaly.
Bolanowski M; Jedrzejuk D; Milewicz A; Arkowska A
Osteoporos Int; 2002; 13(4):303-8. PubMed ID: 12030545
[TBL] [Abstract][Full Text] [Related]
20. Effects of 12 months of recombinant growth hormone therapy on parameters of bone metabolism and bone mineral density in patients on chronic hemodialysis.
Kotzmann H; Riedl M; Pietschmann P; Schmidt A; Schuster E; Kreuzer S; Kainberger F; Frisch H; Geyer G; Hörl WH; Mayer G; Luger A
J Nephrol; 2004; 17(1):87-94. PubMed ID: 15151263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
